11-Year-Old Marley Mae to Make Medical History with Experimental NARS-1 Treatment

Marley Mae's Diagnosis and Rare Condition

• 👧 Marley Mae is an 11-year-old girl diagnosed with NARS-1, an ultra-rare genetic disorder.
• 💔 The diagnosis, received in early 2023, was described as a "gut punch" by her parents, as doctors provided little information and stated there was no known treatment.
• 🧠 NARS-1 causes neurological and developmental challenges, limiting Marley's ability to engage in conversation beyond expressing basic needs.
• 🌍 Experts estimate fewer than 100 people worldwide have been diagnosed with NARS-1, making it extremely rare.

Enlorum Foundation and Experimental Treatment

• 🤝 The Mansour family connected with Enlorum, a California-based foundation specializing in developing experimental treatments for rare genetic diseases.
• 💊 Enlorum provides these experimental medicines free of charge for life to patients.
• 🔬 Stan Crook, a former pharmaceutical CEO and founder of Enlorum, believes they have developed a drug that may treat NARS-1.
• 🌟 Marley Mae is set to become the first patient ever to receive this experimental treatment.

Hope for the Future

• 🙏 While acknowledging that nothing is guaranteed, Marley's parents have faith in the treatment and hope for her future.
• 🗣️ They aspire for Marley to one day be able to tell her own story independently.
• 💖 The development offers significant hope for Marley and potentially other individuals affected by NARS-1.
• 🏥 The treatment will be administered by a doctor from UT Southwestern.